Thoratec May Be Acquisition Target For Firm With Access To Cardiologists
This article was originally published in The Gray Sheet
Executive Summary
Thoratec may seek to be acquired by a larger cardiac rhythm management or heart surgery concern to help bolster referrals for its HeartMate left-ventricular assist device (LVAD) destination therapy